Insider Transactions in Q4 2020 at Biogen Inc. (BIIB)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2020
|
Robin Kramer Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22
-5.57%
|
$5,368
$244.09 P/Share
|
|
Dec 03
2020
|
Robin Kramer Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
74
+15.78%
|
-
|
|
Dec 01
2020
|
Chirfi Guindo Head of Glob Prod Strat & Com |
SELL
Payment of exercise price or tax liability
|
Direct |
562
-7.17%
|
$136,566
$243.16 P/Share
|
|
Dec 01
2020
|
Chirfi Guindo Head of Glob Prod Strat & Com |
BUY
Exercise of conversion of derivative security
|
Direct |
481
+10.72%
|
-
|
|
Nov 30
2020
|
Michel Vounatsos Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,100
+8.18%
|
$747,100
$241.31 P/Share
|
|
Nov 04
2020
|
Alfred Sandrock Head of Research & Development |
SELL
Open market or private sale
|
Direct |
1,500
-10.3%
|
$525,000
$350.0 P/Share
|